Sherket Peterson, PhD

home / authors / sherket-peterson-phd

Sherket Peterson, PhD, is a director of Clinical Development & Scientific Innovation for Aesthetics Medicine at Allergan Aesthetics, an AbbVie company.

Articles

Bridging the Communication Gap Between Providers and Patients Through the Skin Quality Index

Bridging the Communication Gap Between Providers and Patients Through the Skin Quality Index

Marie Bosslett, Assistant Editor;Sherket Peterson, PhD
April 4th 2025

Allergan’s latest initiative hopes to empower both patients and clinicians while advancing industry standards, according to Sherket Peterson, PhD.

Allergan Aesthetics' Effort to Create a Unified Vocabulary for Skin Quality

Allergan Aesthetics' Effort to Create a Unified Vocabulary for Skin Quality

Marie Bosslett, Assistant Editor;Sherket Peterson, PhD
April 4th 2025

Sherket Peterson, PhD, spoke to Dermatology Times about Allergan’s recent research and plan to launch a universal skin quality index.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
4 experts are featured in this series.
Published: April 1st 2025 | Updated: April 10th 2025
Quality of Life Impact: Supporting Patients With GPP
2 experts in this video
Published: April 4th 2025 | Updated: April 10th 2025
Safety Considerations for IL-17 Inhibitors
2 experts in this video
Published: April 4th 2025 | Updated: April 10th 2025
Selecting and Dosing IL-17 Inhibitors in Psoriasis
2 experts in this video
Published: March 28th 2025 | Updated: April 10th 2025
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
2 experts in this video
Published: March 28th 2025 | Updated: April 10th 2025
Clinical Attributes of IL-17 Inhibitors in Psoriasis
© 2025 MJH Life Sciences

All rights reserved.